Cagol 600/ 50/300 mg Film-coated tablets
PDF Leaflet Revision Date: 7 June 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of HIV infection in adults and adolescents.
Dosage (summary)
One tablet once daily for adults and adolescents (u226540kg).
Onset of Action / Duration
Onset: 6 weeks, Duration: not specified
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to teratogenicity risks.
Key Drug Interactions
- Dofetilide
- Pilsicainide
- Metformin
- Etravirine
- Rifampicin
Contraindications
- Hypersensitivity to components
- Moderate/severe hepatic impairment
- Renal impairment (CrCl < 50 ml/min)
- Pregnancy
- Lactation
Common side effects
- Hypersensitivity reactions
- Nausea
- Diarrhoea
- Fatigue
- Rash
Counselling Points
- Inform about hypersensitivity risks and symptoms.
- Do not restart if hypersensitivity occurs.
- Regular monitoring of liver function and viral load is essential.
- Avoid alcohol and other medications that may interact.
Serious warnings
- Severe hypersensitivity reactions
- Lactic acidosis
- Cardiovascular events
Important Disclaimer
The Cagol 600/ 50/300 mg Film-coated tablets professional information leaflet below is the property of Emcure Pharmaceuticals Sa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
